AI medical writing market seen topping $2 billion by 2030

By AI, Created 11:08 AM UTC, May 20, 2026, /AGP/ – The Business Research Company projects the artificial intelligence in medical writing market will exceed $2 billion in 2030, with North America and the U.S. leading growth. The report points to regulatory pressure, demand for transparent AI, and compliance risks as major drivers through 2030.

Why it matters: - The artificial intelligence in medical writing market is moving from a niche workflow tool to a larger compliance and content-automation category. - The market is projected to top $2 billion by 2030. - The segment is expected to grow alongside stricter AI governance, more clinical documentation, and rising demand for faster medical content. - The report says the market will represent about 1% of the broader artificial intelligence market by 2030 and nearly 0.01% of the total information technology market.

What happened: - The Business Research Company published a 2026 market report covering global artificial intelligence in medical writing trends and forecasts through 2035. - North America is projected to be the largest region in 2030, at $0.74 billion. - The North American market is forecast to rise from $0.39 billion in 2025 to $0.74 billion in 2030, a 14% CAGR. - The USA is projected to be the largest country in the market in 2030, at $0.66 billion. - The U.S. market is forecast to grow from $0.34 billion in 2025 to $0.66 billion in 2030, also at a 14% CAGR. - The report estimates a 15% CAGR for the global market through 2030. - The company made the report available through a free sample request and a full report page.

The details: - Clinical writing is projected to be the largest segment by type in 2030. - Clinical writing is expected to account for 55% of the market, or about $1 billion. - The report says clinical writing will benefit from its role in regulatory documentation, growing use of AI automation, and rising clinical trial complexity. - Scientific writing and other types are also identified as major growth areas. - Together, clinical writing, scientific writing, and other types are expected to add more than $2.2 billion in market value from 2025 to 2030. - The report breaks the market down by application into regulatory documentation, automated literature review, language translation, pharmacovigilance, and content modularization. - The report breaks the market down by end use into medical devices, pharmaceutical, biotechnology, and other users. - The report says clinical writing is projected to grow by $1 billion over the next five years. - Scientific writing is projected to grow by $1 billion over the same period. - Other types are projected to grow by $0.2 billion.

Between the lines: - The forecast ties market growth to the pressure on pharmaceutical, biotechnology, and healthcare organizations to prove AI systems are transparent, fair, and auditable. - Regulatory frameworks, including the EU AI Act and sector-specific rules, are pushing demand for compliance-ready documentation and audit trails. - The report also links adoption to the business risk of biased algorithms, including lawsuits, penalties, and reputational damage. - The strongest demand appears to be in use cases where AI can cut turnaround time without weakening documentation quality or compliance. - The regional outlook suggests early adoption is concentrated in the U.S. and other mature healthcare markets with deeper AI vendor ecosystems.

What’s next: - The market is expected to keep expanding through 2030 as regulated industries increase AI use in documentation and review workflows. - Demand will likely rise for tools that generate audit records, fairness checks, and standardized reports. - Clinical writing should remain the biggest commercial opportunity, while scientific writing and other segments add incremental growth. - The report says responsible AI rules and compliance risk management will continue to shape technology adoption across healthcare and life sciences.

The bottom line: - AI in medical writing is becoming a compliance-driven growth market, not just a productivity tool.